B. Riley Wealth Advisors’s ENDRA Life Sciences NDRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1
Closed -$65K 1446
2021
Q2
$65K Hold
1
﹤0.01% 1337
2021
Q1
$78K Hold
1
﹤0.01% 1312
2020
Q4
$23K Hold
1
﹤0.01% 1021
2020
Q3
$19K Hold
1
﹤0.01% 935
2020
Q2
$24K Hold
1
﹤0.01% 855
2020
Q1
$17K Hold
1
﹤0.01% 777
2019
Q4
$39K Hold
1
﹤0.01% 817
2019
Q3
$25K Hold
1
﹤0.01% 802
2019
Q2
$40K Hold
1
﹤0.01% 778
2019
Q1
$39K Hold
1
﹤0.01% 729
2018
Q4
$35K Buy
+1
New +$116K 0.01% 656

Other funds holding NDRA

B. Riley Wealth Advisors's NDRA Position: Q3 2021 in Review

B. Riley Wealth Advisors sold out of ENDRA Life Sciences (NDRA) in Q3 2021, closing a stake of 1 share — an estimated $65K sold.

B. Riley Wealth Advisors first reported a position in NDRA in Q4 2018 and held it in 11 quarters. The position peaked at $78K in Q1 2021. 11 funds tracked by Wall St. Rank hold NDRA as of Q3 2021.

  • B. Riley Wealth Advisors reported no remaining ENDRA Life Sciences position as of Q3 2021 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1 ENDRA Life Sciences share in Q3 2021, an estimated $65K.
  • B. Riley Wealth Advisors first reported a position in ENDRA Life Sciences in Q4 2018 and held it in 11 quarters.
  • B. Riley Wealth Advisors's ENDRA Life Sciences position peaked at $78K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q3 2021.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.